Aspivix is a medical device company in women’s health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, Carevix™, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. Carevix™ is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. Carevix™ study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the pain by up to 73% and the bleeding by up to 78% in IUD insertions. More than 100 million women worldwide have procedures using the antiquated single-tooth tenaculum, an instrument invented over a century ago, without consideration of a woman's anatomy or pain, and yet it is still considered to be the standard of care in gynecology. At Aspivix, we think women deserve more. We are driven by our vision to make gynecology modern.
View Top Employees from AspivixWebsite | http://www.aspivix.com |
Revenue | $1 million |
Employees | 16 (9 on RocketReach) |
Founded | 2015 |
Address | 5 Chemin Du Closel, Renens VD, Vaud 1020, CH |
Phone | +41 76 327 87 97 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Manufacturing General, Health Care, Manufacturing, Medical, Medical Device, Women's |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Aspivix employee's phone or email?
The Aspivix annual revenue was $1 million in 2024.
9 people are employed at Aspivix.
Aspivix is based in Renens VD, Vaud.
The NAICS codes for Aspivix are [339, 33].
The SIC codes for Aspivix are [38, 384].